At AstraZeneca, we are committed to driving healthcare system transformation to improve outcomes for patients living with amyloidosis around the world. The launch of the global Accelerate Change Together (ACT) on Amyloidosis programme demonstrates our dedication to working with the broader healthcare community to achieve shared goals and transform amyloidosis care.